Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
lagricel ofteno
- Development stage
- Phase 4
- Lead developer
- Laboratorios Sophia
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Administration
- Ophthalmic
01
Overview
Lagricel Ofteno is an ophthalmic solution containing sodium hyaluronate (a derivative of hyaluronic acid) as its active ingredient. It is primarily used as an eye lubricant for the treatment and relief of dry eye symptoms and ocular surface irritation. Sodium hyaluronate acts by mimicking natural tears, providing lubrication and moisture to the ocular surface, promoting corneal healing after procedures such as photorefractive keratectomy (PRK), and improving comfort in patients with dry eye disease. The mechanism of action involves enhancing tear film stability and protecting epithelial cells on the ocular surface through its viscoelastic properties[1][3][7]. Clinical studies have evaluated both single-dose and multi-dose formulations for safety, tolerability, and efficacy in conditions like dry eye disease and post-PRK recovery[3][6][8].
- Brand names
- Lagricel Ofteno
- Other names
- Lagricel Ofteno PFLagricel Ofteno monodoseLagricel Ofteno multidose
Beyond the preview
Go deeper on lagricel ofteno.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on lagricel ofteno.